管理多发性硬化症初始表现的方法:全球实践调查
Jodie I Roberts1, Aravind Ganesh1, Luca Bartolini1
1Department of Clinical Neurosciences (JIR, AG), University of Calgary, Canada; Neuroimmunology Centre (JIR, TK), Department of Neurology, Royal Melbourne Hospital; Clinical Outcomes Research Unit (JIR, TK), Department of Medicine, University of Melbourne, Australia; Hotchkiss Brain Institute (JIR, AG), University of Calgary, Canada; and Hasbro Children's Hospital (LB), Brown University, Providence, RI.
Neurology. Clinical practice
|October 14, 2024
概括
早期高效疗法可能会改善多发性硬化症 (MS) 患者的治疗结果. 这项调查探讨了医生在管理复发性复发性多发性硬化症方面的全球实践,揭示了关于最佳治疗策略的分歧意见.
科学领域:
- 神经学 神经学
- 临床实践 临床实践
- 多发性硬化症管理管理
背景情况:
- 多发性硬化症 (MS) 的疾病修饰疗法 (DMT) 正在扩大.
- 新出现的证据表明,早期高效疗法可以改善治疗结果.
- 目前在治疗复发性复发性多发性硬化 (RRMS) 的现实实践差异尚不清楚.
研究的目的:
- 探索RRMS的现有管理策略中的实践变化.
- 了解医生对初步调查,复发管理和DMT选择的方法.
主要方法:
- 全球电子调查通过Neurology®临床实践分发.
- 受访者提到一个37岁的女性患有视神经炎的病例.
- 根据人口统计学变量分析和分层对应答案.
主要成果:
- 收到来自42个国家的153个回复.
- 高剂量的皮质类固醇是偏好的复发治疗 (87.7%).
- 56.6%的人最初选择了高效的DMT,其中最常见的是fingolimod,natalizumab和dimethyl fumarate.
结论:
- 在MS诊断早期启动高效的DMT存在轻微偏好.
- 关于RRMS最佳治疗模式的医生意见仍然存在分歧.
- 需要进一步的研究,以建立最终的最佳实践.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Parkinson's Disease: Overview
487
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
487
Methods of Documentation VI: Case Management Model
559
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
559
Atherosclerosis IV: Nursing Management
2
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
2


